Review of long-acting reversible contraceptives (LARC)

Learn about how the Medicare Benefits Schedule (MBS) Review Advisory Committee (MRAC) is reviewing long-acting reversible contraceptive MBS items.

About the review

The MRAC is conducting a review of long-acting reversible contraceptives (LARC).

In June 2024, the Minister for Health , requested the MRAC undertake a phased review of MBS items for the insertion and removal of long-acting reversible contraceptives. This review is part of the Government’s commitment to invest in Women’s Health.

A working group was established to lead this review and report back to the full committee on its findings.

Who we work with

The Long-Acting Reversible Contraceptives (LARC) working group members lead this review and report back to the full committee on its findings.

Long-Acting Reversible Contraceptives (LARC) working group members

MemberArea of specialty or expertise
Professor Sally Green (Chair)Health systems
Ms Jan DonovanConsumer Representative
Conjoint Professor Anne Duggan (MRAC Chair)Gastroenterologist
Associate Professor Elizabeth MarlesGeneral Practice / Indigenous Health and Health Policy
Dr Sue MaselRural General Practice
Professor Rosalie VineyHealth Economist
Departmental Medical Adviser 
Associate Professor Andrew SingerPrincipal Medical Adviser, Department of Health

Why the review is important

A review of LARC MBS items will support the Government’s ongoing commitment to improve health outcomes for women and girls in Australia, including providing an opportunity for the department to consider how to more broadly support awareness and high-quality provision of these important services.

Status 

The review is being undertaken in two phases. The MRAC recommendations relating to phase one of this review informed a number of changes from 1 November 2025, including increased fees for LARC items, introduction of new LARC administration items for nurse practitioners, and the introduction of loading items that will incentivise GPs, nurse practitioners and specialists to deliver LARC insertion and removal services at no cost to the patient.

Phase two of this review includes consideration of creating MBS items or other mechanisms to support payment specific to delivering LARC services by other health workers, such as endorsed midwives.

At the 19 August meeting, the committee endorsed the phase two recommendations of the LARC working group to be included in a Draft Report which will undergo an open consultation process. Feedback received from this process will be considered by the committee to help inform the Final Report which will be provided to government for consideration.

Activities to date

DateActivity
19 August 2025The MRAC endorsed the phase two recommendations of the LARC working group 
22 July 2025Third meeting of LARC working group held 
5 May 2025 Second meeting of LARC working group held
9 February 2025Government announces funding package which supports LARC services to be provided to patients at low or no cost.
Read the announcement
September 2024MRAC recommendations provided to government
20 August 2024 The MRAC endorsed the recommendations 
23 July 2024First meeting of LARC working group held
16 July 2024Targeted stakeholder consultation workshop held

Contact

MBS Continuous Review contact

Contact us with questions about the Medicare Benefits Schedule (MBS) Continuous Review.
Date last updated:

Help us improve health.gov.au

If you would like a response please provide an email address. Your email address is covered by our privacy policy.